VCAM1 and metabolic dysfunction-associated steatotic liver disease: The markers of inflammation with potential use as biomarkers in NAFLD include other molecules involved in the complex inflammatory signaling, as is the case with the vascular cell adhesion molecule 1 (VCAM-1).